Group devises tools aimed at hastening cancer-drug approvals

09/21/2008 | Yahoo!

The National Cancer Institute's Translational Research Working Group developed a set of tools designed to expedite and streamline the development and FDA approval of cancer treatments. "Pathways to Clinical Goals" features flowcharts aimed at improving research procedures and addresses areas including anti-cancer agents, biospecimen-based assessment techniques and intervention devices.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA